An 18-month, open-label, single-arm safety extension study of an age-and bodyweightadjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children and young adults from 1 to 18 years of age with chronic kidney disease and proteinuria

  • Lanzersdorfer, Roland (PI)

Project: Clinical studiesClinical Study (Industry project)

Project Details

StatusActive
Effective start/end date10.01.202330.06.2028

Fields of science

  • 302035 Paediatrics and adolescent medicine